Belite Bio Financials - Benzinga

Belite Bio Inc

BLTENASDAQ

Trade with Public

Trade with Public

$165.93

-1.40-0.84%

近くで: Sep 28, 5:00 PM EST

$165.93

N/A

時間外: 4:00 PM EST

概要ニュース業績予想イベント目標株価財務センチメント株主構成比較株式レポート

Belite Bio Financials

Belite Bio (BLTE) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Belite Bio Q2 Adj. EPS $(0.54) Beats $(0.79) Estimate

Belite Bio (NASDAQ:BLTE) reported quarterly losses of $(0.54) per share which beat the analyst consensus estimate of $(0.79) by 31.65 percent. This is a 8 percent decrease over losses of $(0.50) per share from the same

Benzinga Newsdesk

Earnings Scheduled For May 20, 2026

Benzinga Insights

PRO
Belite Bio Q1 EPS $(0.45) Beats $(0.63) Estimate

Belite Bio (NASDAQ:BLTE) reported quarterly losses of $(0.45) per share which beat the analyst consensus estimate of $(0.63) by 28.57 percent. This is unchanged from the same period last year.

Benzinga Newsdesk

PRO
Belite Bio Q4 EPS $(0.70) Misses $(0.54) Estimate

Belite Bio (NASDAQ:BLTE) reported quarterly losses of $(0.70) per share which missed the analyst consensus estimate of $(0.54) by 29.15 percent. This is a 118.75 percent decrease over losses of $(0.32) per share from the

Benzinga Newsdesk

Earnings Scheduled For March 2, 2026

Benzinga Insights

Exploring Belite Bio's Earnings Expectations

Benzinga Insights

© 2026 Benzinga | All Rights Reserved